BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26053182)

  • 1. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.
    Gonnissen A; Isebaert S; Haustermans K
    Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
    Huang L; Walter V; Hayes DN; Onaitis M
    Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting GLI Transcription Factors in Cancer.
    Didiasova M; Schaefer L; Wygrecka M
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonclassical hedgehog-GLI signaling and its clinical implications.
    Shevde LA; Samant RS
    Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened.
    Pietrobono S; Gagliardi S; Stecca B
    Front Genet; 2019; 10():556. PubMed ID: 31244888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting GLI factors to inhibit the Hedgehog pathway.
    Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
    Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance.
    Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F
    Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
    Katoh M
    Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
    Li B; Fei DL; Flaveny CA; Dahmane N; Baubet V; Wang Z; Bai F; Pei XH; Rodriguez-Blanco J; Hang B; Orton D; Han L; Wang B; Capobianco AJ; Lee E; Robbins DJ
    Cancer Res; 2014 Sep; 74(17):4811-21. PubMed ID: 24994715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy.
    Réda J; Vachtenheim J; Vlčková K; Horák P; Vachtenheim J; Ondrušová L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model.
    Garcia N; Ulin M; Ali M; Al-Hendy A; Carvalho KC; Yang Q
    Reprod Sci; 2022 Mar; 29(3):781-790. PubMed ID: 34642915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
    Rovida E; Stecca B
    Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of Smoothened for therapeutic gain.
    Ruat M; Hoch L; Faure H; Rognan D
    Trends Pharmacol Sci; 2014 May; 35(5):237-46. PubMed ID: 24703627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli.
    Zhan X; Wang J; Liu Y; Peng Y; Tan W
    Mol Cancer; 2014 Jan; 13():4. PubMed ID: 24393163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
    Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
    Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling mechanism and role in cancer.
    Jiang J
    Semin Cancer Biol; 2022 Oct; 85():107-122. PubMed ID: 33836254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.
    Di Magno L; Coni S; Di Marcotullio L; Canettieri G
    Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.